Nevro Corp (NVRO)
5.67 x 1 5.72 x 4
Post-market by (Cboe BZX)
5.72 unch (unch) 02/13/25 [NYSE]
5.67 x 1 5.72 x 4
Post-market 5.71 -0.01 (-0.17%) 19:00 ET
for Thu, Feb 13th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 425,174 | 406,365 | 386,905 | 362,048 | 390,255 |
Cost of Goods | 135,114 | 129,998 | 120,863 | 112,146 | 121,905 |
Gross Profit | 290,060 | 276,367 | 266,042 | 249,902 | 268,350 |
Operating Expenses | 389,482 | 271,201 | 377,839 | 312,900 | 365,734 |
Operating Income | -99,308 | 6,164 | -110,934 | -62,852 | -96,479 |
Interest Expense | 8,014 | 6,432 | 19,749 | 21,806 | 10,931 |
Other Income | 9,463 | 4,532 | -143 | 2,461 | 5,323 |
Pre-tax Income | -97,859 | 4,264 | -130,826 | -82,197 | -102,087 |
Income Tax | -5,646 | 1,263 | 534 | 868 | 1,599 |
Net Income Continuous | -92,213 | 3,001 | -131,360 | -83,065 | -103,686 |
Net Income | $-92,213 | $3,001 | $-131,360 | $-83,065 | $-103,686 |
EPS Basic Total Ops | -2.56 | 0.08 | -3.77 | -2.47 | -3.37 |
EPS Basic Continuous Ops | -2.56 | 0.09 | -3.77 | -2.47 | -3.37 |
EPS Diluted Total Ops | -2.56 | 0.08 | -3.77 | -2.47 | -3.37 |
EPS Diluted Continuous Ops | -2.56 | 0.08 | -3.77 | -2.47 | -3.37 |
EPS Diluted Before Non-Recurring Items | -2.46 | -2.72 | -3.20 | -2.47 | -3.37 |
EBITDA(a) | $-90,502 | $18,112 | $-87,483 | $-39,400 | $-82,804 |